Former Sandoz Inc. CEO Don DeGolyer Leads PharmaTech Startup Ategenos as Company Prepares Public Launch
Veteran pharmaceutical leader Don DeGolyer, former CEO of Sandoz Inc., has co-founded Ategenos, a PharmaTech startup preparing for its public launch. The company aims to tackle the global crisis of medication non-adherence, a problem costing $1 trillion worldwide.